John Overdeck Two Sigma Investments
John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$510M |
| 2 |
Broadcom
AVGO
|
+$318M |
| 3 |
Marvell Technology
MRVL
|
+$290M |
| 4 |
Salesforce
CRM
|
+$263M |
| 5 |
Advanced Micro Devices
AMD
|
+$250M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$255M |
| 2 |
Progressive
PGR
|
+$244M |
| 3 |
Visa
V
|
+$238M |
| 4 |
Lam Research
LRCX
|
+$201M |
| 5 |
Elevance Health
ELV
|
+$190M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.88% |
| 2 | Healthcare | 13.28% |
| 3 | Financials | 10.32% |
| 4 | Industrials | 9.79% |
| 5 | Consumer Discretionary | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVEE
2301
DELISTED
NV5 Global
NVEE
| $693K | ﹤0.01% |
35,938
-151,291
| -81% | -$2.77M |
|
2302
Vitamin Cottage Natural Grocers
NGVC
$651M
| $691K | ﹤0.01% |
17,189
-39,004
| -69% | -$1.63M |
|
|
YMAB
2303
DELISTED
Y-mAbs Therapeutics
YMAB
| $686K | ﹤0.01% |
154,785
+66,448
| +75% | +$386K |
|
2304
United States Antimony
UAMY
$778M
| $685K | ﹤0.01% |
311,458
-7,622
| -2% | -$13.2K |
|
|
FBRT
2305
Franklin BSP Realty Trust
FBRT
$704M
| $685K | ﹤0.01% |
+53,759
| New | +$694K |
|
2306
Compass Diversified
CODI
$867M
| $684K | ﹤0.01% |
+36,656
| New | +$757K |
|
2307
Powell Industries
POWL
$6.93B
| $684K | ﹤0.01% |
12,048
+3,336
| +38% | +$233K |
|
2308
Mistras Group
MG
$605M
| $684K | ﹤0.01% |
64,618
+32,357
| +100% | +$319K |
|
2309
Schwab US Large- Cap ETF
SCHX
$74B
| $683K | ﹤0.01% |
30,936
-368,400
| -92% | -$8.58M |
|
2310
Treace Medical Concepts
TMCI
$313M
| $682K | ﹤0.01% |
81,303
-72,521
| -47% | -$652K |
|
|
CRON
2311
Cronos Group
CRON
$1.29B
| $682K | ﹤0.01% |
376,692
-757,536
| -67% | -$1.46M |
|
2312
China Yuchai International
CYD
$1.48B
| $680K | ﹤0.01% |
+40,046
| New | +$614K |
|
2313
Caterpillar
CAT
$373B
| $677K | ﹤0.01% |
2,052
+152
| +8% | +$54.1K |
|
2314
Gogo Inc
GOGO
$369M
| $677K | ﹤0.01% |
78,500
-23,278
| -23% | -$182K |
|
2315
Graham Holdings Company
GHC
$4.99B
| $673K | ﹤0.01% |
700
-249
| -26% | -$232K |
|
2316
SoundThinking
SSTI
$81M
| $672K | ﹤0.01% |
39,624
-9,095
| -19% | -$135K |
|
2317
GS ActiveBeta US Small Cap Equity ETF
GSSC
$1.09B
| $666K | ﹤0.01% |
10,500
-8,600
| -45% | -$586K |
|
2318
Flowserve
FLS
$10.2B
| $665K | ﹤0.01% |
+13,608
| New | +$773K |
|
2319
Backblaze
BLZE
$946M
| $664K | ﹤0.01% |
137,396
-135,442
| -50% | -$834K |
|
2320
Clearwater Paper
CLW
$351M
| $662K | ﹤0.01% |
26,083
-74,432
| -74% | -$2.07M |
|
|
FITE
2321
State Street SPDR S&P Kensho Future Security ETF
FITE
$146M
| $659K | ﹤0.01% |
10,500
+6,800
| +184% | +$459K |
|
2322
Surgery Partners
SGRY
$1.84B
| $658K | ﹤0.01% |
27,697
-15,641
| -36% | -$370K |
|
2323
Adtran
ADTN
$653M
| $656K | ﹤0.01% |
75,202
-21,766
| -22% | -$219K |
|
2324
Investar Holding Corp
ISTR
$417M
| $655K | ﹤0.01% |
37,204
+14,173
| +62% | +$266K |
|
|
PINE
2325
Alpine Income Property Trust
PINE
$347M
| $655K | ﹤0.01% |
39,178
+7,107
| +22% | +$118K |
|
Similar funds
John Overdeck's Q1 2025 Portfolio in Review
As of Q1 2025, John Overdeck held 3,617 positions worth $46.8B, up 2% from $45.9B the previous quarter. Its ten largest holdings account for 8.1% of the portfolio.
John Overdeck deployed $2.08B of net new capital in Q1 2025, opening 458 new positions and adding to 1,225 existing holdings. Its largest new stake was Advanced Micro Devices: 2,246,952 shares worth $231M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Eli Lilly, an estimated $255M trimmed.
- John Overdeck's largest Q1 2025 buy was Advanced Micro Devices: 2,246,952 shares worth $231M.
- John Overdeck added most to State Street SPDR S&P 500 ETF Trust in Q1 2025, an estimated $510M increase.
- John Overdeck's biggest Q1 2025 reduction was Eli Lilly, cutting an estimated $255M.
- John Overdeck fully exited Coinbase in Q1 2025, selling an estimated $45M.
- John Overdeck's ten largest holdings make up 8.1% of its $46.8B portfolio in Q1 2025.
- John Overdeck opened 458 new positions and closed 452 in Q1 2025.
- John Overdeck's portfolio value rose 2% quarter-over-quarter to $46.8B.
Based on Two Sigma Investments's 13F filing for Q1 2025, filed 15 May 2025.